drugset
drugset / Trial / NCT00350142

Trilogy Stereotactic Body Radiotherapy for Pancreatic Cancer

NCT00350142 ↗

Phase 2 Completed 20 enrolled Albert Koong
NaSingle-groupOpen-labelTreatment

Summary

This study will assess the efficacy of treating locally advanced pancreatic cancer using Stereotactic Body Radiotherapy (using Trilogy) and Gemcitabine

Timeline

Start
2006-04
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Gemcitabine Small molecule 1000 mg/m2 —

Indications

malignant pancreatic neoplasm